Tower Research Capital (TRC)’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $150K | Sell |
|
|||||
|
2025
Q2 | $980K | Buy |
|
|||||
|
2025
Q1 | $66.5K | Sell |
|
|||||
|
2024
Q4 | $450K | Buy |
|
|||||
|
2024
Q3 | $53.3K | Sell |
|
|||||
|
2024
Q2 | $367K | Buy |
|
|||||
|
2024
Q1 | $22.3K | Sell |
|
|||||
|
2023
Q4 | $92.1K | Buy |
|
|||||
|
2023
Q3 | $52.9K | Sell |
|
|||||
|
2023
Q2 | $93.3K | Sell |
|
|||||
|
2023
Q1 | $150K | Buy |
|
|||||
|
2022
Q4 | $116K | Buy |
|
|||||
|
2022
Q3 | $35K | Sell |
|
|||||
|
2022
Q2 | $77K | Sell |
|
|||||
|
2022
Q1 | $328K | Buy |
|
|||||
|
2021
Q4 | $37K | Sell |
|
|||||
|
2021
Q3 | $40K | Sell |
|
|||||
|
2021
Q2 | $68K | Buy |
|
|||||
|
2021
Q1 | $26K | Sell |
|
|||||
|
2020
Q4 | $98K | Buy |
|
|||||
|
2020
Q3 | $49K | Buy |
|
|||||
|
2020
Q2 | $38K | Buy |
|
|||||
|
2020
Q1 | $14K | Sell |
|
|||||
|
2019
Q4 | $68K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $26K | Buy |
|